Cancer News and Research

Latest Cancer News and Research

Defective nucleoli linked to Parkinson's disease

"Nucleolus", or small nucleus, is the term coined by early biologists for the tiny structure within the nucleus which they saw under the microscope. In this structure within the nucleus, RNA molecules and proteins are assembled to form ribosomes, the true protein factories of cells.

2 Feb 2011

New Spanish version of ASPIRE for Hispanic teens

The University of Texas MD Anderson Cancer Center's popular web-based teen prevention and smoking-cessation program, ASPIRE, now speaks Spanish.

2 Feb 2011

Trained dog sniffs out colon cancer with 98% accuracy

For the study the researchers at Kyushu University trained an 8-year-old female Labrador retriever named Marine who was given breath and stool samples of 306 patients, collected right before they received colonoscopies.

2 Feb 2011

Microbubble contrast- enhanced ultrasound improves identification of sentinel lymph node in breast biopsies

Using "microbubbles" and ultrasound can mean more targeted breast biopsies for patients with early breast cancer, helping to determine treatment and possibly saving those patients from undergoing a second breast cancer surgery, a new study in shows.

2 Feb 2011

Study finds treatment-related mortality with bevacizumab in cancer patients

Cancer patients treated with the chemotherapy agent bevacizumab may be at an increased risk of treatment-related death when the drug is used in combination with other therapies.

2 Feb 2011

Bioengineers and physician-scientists zap tumors with light-activated nanoparticles

Rice University bioengineers and physician-scientists at Baylor College of Medicine and Texas Children's Hospital have successfully destroyed tumors of human brain cancer cells in the first animal tests of a minimally invasive treatment that zaps glioma tumors with heat. The tests involved nanoshells, light-activated nanoparticles that are designed to destroy tumors with heat and avoid the unwanted side effects of drug and radiation therapies.

2 Feb 2011

Quebec provides access to new treatment for women with postmenopausal osteoporosis

Today Quebec is providing access to a therapy in a new class of osteoporosis treatments. With Quebec being the first province to list Prolia on public and private drug plans, Canadians living with osteoporosis in the province of Quebec now have access to increased treatment options.

2 Feb 2011

Scientists discover breast cancer cells that dodge immune system, promote tumor growth

Scientists discovered a new way breast cancer cells dodge the immune system and promote tumor growth, providing a fresh treatment target in the fight against the disease. While comparable mechanisms to avoid the immune system have been identified in mice with breast and other cancers, the study tested human breast tumor cells, putting researchers closer to understanding how the disease progresses in real patients.

2 Feb 2011

CDH first hospital in New England to use Xenex PX-UV disinfection system

Cooley Dickinson Hospital (CDH) today announced it is the first hospital in New England to use the Xenex PX-UV disinfection system to disinfect its patient and operating rooms.

2 Feb 2011

Pregnant women eating baked clay at risk of cancer, kidney damage and brain damage

Pregnant women eating baked clay could be exposing themselves and their unborn child to toxic chemicals, according to research by De Montfort University (DMU) in Leicester, UK.

2 Feb 2011

EA sponsors research grant to investigate specific cancers and kinase mutations

Expression Analysis today announced a jointly sponsored research grant for up to eight American Cancer Society Grantees to investigate and draw parallels between specific cancers and recurring mutations in specific kinases, using targeted genome sequencing.

2 Feb 2011

PET imaging may play a role in early evaluation of vandetanib response in thyroid cancer

Positron emission tomography can image metabolic changes following treatment with the protein kinase inhibitor vandetanib, helping to define the therapy response or the effectiveness of the therapeutic agent, according to research published in the February issue of The Journal of Nuclear Medicine.

1 Feb 2011

Seattle Genetics to sell common stock in underwritten public offering

Seattle Genetics, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the offering are to be sold by Seattle Genetics.

1 Feb 2011

FDA approves NCI's Sodium Fluoride F18 NDA for use in bone scans

The FDA has approved a New Drug Application from the National Cancer Institute, part of the National Institutes of Health, for a new strength of a previously approved drug, Sodium Fluoride F18, for use in bone scans.

1 Feb 2011

Genzyme's diagnostic products sold to Sekisui Chemical for $265 million

Genzyme Corporation today announced that it has completed the sale of its diagnostic products business to Sekisui Chemical Co., Ltd. for $265 million in cash.

1 Feb 2011

OPKO Health acquires CURNA

OPKO Health, has acquired CURNA, a privately held company based in Jupiter, Florida, engaged in the discovery of new drugs for the treatment of a wide variety of illnesses, such as cancer, heart disease, metabolic disorders and genetic anomalies.

1 Feb 2011

John Snow sponsors MEDEA 2011 conference

John Snow, Inc. (JSI) is a proud sponsor of MEDEA 2011, a two-day conference (February 1 and 2) dedicated to improving the country of Georgia's health system by the year 2020. The conference, led by the government of Georgia, brings together high level Georgian and American health professionals to begin to solve some of the country's most pressing health problems.

1 Feb 2011

Potential adverse effects of radiations on children's health

COST Action BM0704 is delighted to have as co-organisers of the Conference the International Commission on Non-Ionizing Radiation Protection (ICNIRP), the German Federal Office for Radiation Protection (BfS), the World Health Organization (WHO), the European Bioelectromagnetics Association (EBEA) and the European Society for Skin Cancer Prevention (EUROSKIN).

1 Feb 2011

AVEO commences enrollment in tivozanib Phase 2 study in renal cell carcinoma

AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).

1 Feb 2011

Elsevier announces publication of two position statements from EMAS in Maturitas journal

Elsevier announced today the publication of two further important position statements from the European Menopause and Andropause Society in the journal Maturitas on common management problems in the post-reproductive health of women.

1 Feb 2011

Cancer News and Research

Latest Cancer News and Research

Defective nucleoli linked to Parkinson's disease

New Spanish version of ASPIRE for Hispanic teens

Trained dog sniffs out colon cancer with 98% accuracy

Microbubble contrast- enhanced ultrasound improves identification of sentinel lymph node in breast biopsies

Study finds treatment-related mortality with bevacizumab in cancer patients

Bioengineers and physician-scientists zap tumors with light-activated nanoparticles

Quebec provides access to new treatment for women with postmenopausal osteoporosis

Scientists discover breast cancer cells that dodge immune system, promote tumor growth

CDH first hospital in New England to use Xenex PX-UV disinfection system

Pregnant women eating baked clay at risk of cancer, kidney damage and brain damage

EA sponsors research grant to investigate specific cancers and kinase mutations

PET imaging may play a role in early evaluation of vandetanib response in thyroid cancer

Seattle Genetics to sell common stock in underwritten public offering

FDA approves NCI's Sodium Fluoride F18 NDA for use in bone scans

Genzyme's diagnostic products sold to Sekisui Chemical for $265 million

OPKO Health acquires CURNA

John Snow sponsors MEDEA 2011 conference

Potential adverse effects of radiations on children's health

AVEO commences enrollment in tivozanib Phase 2 study in renal cell carcinoma

Elsevier announces publication of two position statements from EMAS in Maturitas journal

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in